(MGA) Mega Uranium - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA58516W1041
MGA EPS (Earnings per Share)
MGA Revenue
MGA: Uranium, Mining, Exploration, Energy
Mega Uranium Ltd. is a uranium-focused company with a diversified portfolio of exploration projects, primarily located in Canada and Australia. The companys assets include the Georgetown project in Queensland, Australia, and the Redport project in Western Australia, showcasing its strategic presence in key uranium-rich regions.
With a history dating back to 1990, the company has evolved through name changes, previously known as Maple Minerals Corp. before adopting its current name in October 2005. Headquartered in Toronto, Canada, Mega Uranium Ltd. is poised to capitalize on its geographical presence and industry expertise.
The companys stock, trading under the ticker symbol MGA, is classified under the Coal & Consumable Fuels sub-industry. Given the current market context, the stocks recent price movements indicate a consolidation phase, with the last price recorded at $0.26. Technical indicators suggest a relatively stable short-term trend, with the 20-day and 50-day Simple Moving Averages (SMA) converging at $0.27, while the 200-day SMA stands at $0.31, indicating a potential resistance level.
Analyzing the
From a fundamental standpoint, Mega Uranium Ltd.s market capitalization stands at $96.71 million CAD, with a negative Return on Equity (RoE) of -4.93%, indicating that the company is currently not generating profits for its shareholders. The absence of P/E and forward P/E ratios further underscores the companys current unprofitability.
Forecasting the stocks future performance involves integrating both technical and fundamental analyses. Given the current technical setup and fundamental challenges, a cautious outlook is warranted. If the company can demonstrate progress in its exploration projects, potentially leading to improved profitability, the stock could experience an upward revaluation. Conversely, failure to address current operational challenges may lead to continued underperformance. Based on the technical indicators, a potential target could be a move towards the 200-day SMA at $0.31, representing a 19% increase from the current price. However, this would require a significant shift in market sentiment and/or positive fundamental developments.
Additional Sources for MGA Stock
MGA Stock Overview
Market Cap in USD | 77m |
Sector | Energy |
Industry | Uranium |
GiC Sub-Industry | Coal & Consumable Fuels |
IPO / Inception |
MGA Stock Ratings
Growth Rating | 46.1 |
Fundamental | -25.6 |
Dividend Rating | 0.08 |
Rel. Strength | -10.8 |
Analysts | - |
Fair Price Momentum | 0.30 CAD |
Fair Price DCF | 0.01 CAD |
MGA Dividends
Currently no dividends paidMGA Growth Ratios
Growth Correlation 3m | 22.1% |
Growth Correlation 12m | -36.1% |
Growth Correlation 5y | 59.6% |
CAGR 5y | 29.67% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | -0.06 |
Alpha | -25.24 |
Beta | 1.306 |
Volatility | 71.74% |
Current Volume | 806.3k |
Average Volume 20d | 359.4k |
As of June 18, 2025, the stock is trading at CAD 0.31 with a total of 806,282 shares traded.
Over the past week, the price has changed by +10.71%, over one month by +19.23%, over three months by +16.98% and over the past year by -7.46%.
Probably not. Based on ValueRay´s Fundamental Analyses, Mega Uranium (TO:MGA) is currently (June 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -25.62 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MGA is around 0.30 CAD . This means that MGA is currently overvalued and has a potential downside of -3.23%.
Mega Uranium has no consensus analysts rating.
According to our own proprietary Forecast Model, MGA Mega Uranium will be worth about 0.4 in June 2026. The stock is currently trading at 0.31. This means that the stock has a potential upside of +12.9%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.4 | 12.9% |